Aspire has successfully submitted Premarket Tobacco Application (PMTA) to be approved by the US Food and Drug Administration (FDA) for its electronic nicotine delivery devices.

The documentation includes a broad and exhaustive investigation with scientific evidence of the quality and safety of our electronic nicotine-delivery systems (ENDS).

Aspire believes in normal and logical regulations to protect the people against harmful tobacco products. We also believe that the ENDS industry should offer high-quality products that comply with health and marketing standards.


Comments are closed.